RCT | Laser treatment does not improve sexual dysfunction in survivors of breast cancer

Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial – JAMA Network Open

Invited commentary: Genitourinary Syndrome of Menopause and the False Promise of Vaginal Laser Therapy – JAMA Network Open

Related:

RCT | Laser no better than sham treatment for genitourinary syndrome of menopause

M-A | Carbon dioxide laser vs. vaginal estrogen for genitourinary syndrome of menopause.

Perspective: From vaginal laser treatment to spa breaks – it’s the great menopause gold rush.

RCT: Laser treatment not better than sham treatment on symptom severity in women with postmenopausal vaginal symptoms.

Consensus Document: The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology

Commentary on Twitter

The LIGHT Trial RCT: Vaginal laser therapy does not improve sexual dysfunction/genitourinary syndrome of menopause in breast cancer survivors receiving aromatase inhibitors when added to first line therapy based on moisturizers and vibrator stimulation. https://t.co/jdVDgHe9HC

— JAMA Network Open (@JAMANetworkOpen) February 10, 2023